$0.0011 (0%)

Volume: 14.206k

Closed: Dec 02, 2022

Hollow Logo Score: -7.767

Genocea Biosciences Stock Forecast

$0.0011 (0%)

Volume: 14.206k

Closed: Dec 02, 2022

Score Hollow Logo -7.767

Genocea Biosciences Stock Statistics NASDAQ:GNCA

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-01 - 2022-12-02 SELL 0
2022-11-30 - 2022-12-01 BUY -86.08
2022-11-23 - 2022-11-30 SELL 777.78
2022-11-17 - 2022-11-23 BUY -85.94
2022-11-08 - 2022-11-17 SELL 392.31

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE